Objective Natural cycle IVF combined with IVM has been recently proposed as an alternative strategy to the standard ovarian stimulation protocols. In Mexico, where the costs of the medications represent about 30-40% of the total treatment price, such an approach could be appealing. Here we report the initial experience of natural cycle IVF/IVM in ovulatory patients with various infertility diagnoses. Design Prospective cases studies Materials and Methods Ten ovulatory infertile patients <35 years were included in this pilot study using the protocol described by Lim and Chian (2009) whereby hCG is the only medication administered when the dominant follicle reaches a 14 mm diameter. Main outcomes evaluated were in vitro maturation rate, clinical pregnancy and implantation rates. Each metaphase oocyte was inseminated by ICSI. Results A total of 69 oocytes were retrieved and no cycles were cancelled. Twelve mature and 57 immature oocytes were retrieved, of which 33 (58%) matured in vitro and 19 (57%) showed normal fertilization after ICSI. All 10 patients had an embryo transfer (3 cases with a single embryo derived from the mature oocyte of the dominant follicle, and the remaining 7 cases with embryos obtained from both mature and immature oocytes (22 embryos total transferred). The implantation rate was 13% with a clinical/ongoing pregnancy of 30% per cycle and transfer (one biochemical pregnancy not included). There were no differences in age or day 3 FSH in the non-pregnant vs. the pregnant group (30.5 vs 31 years and 6.4 vs 7.4 mUI/dL, respectively).
The only significant difference was the size of the nondominant follicles in the non pregnant group (7.5±1.1 mm vs 9.3±1.1 mm, p<0.04) (see details in Table 1 ).
Conclusions Natural cycle with IVM is an effective and appealing treatment for couples that for economical reasons cannot afford conventional IVF. Additional advantages of this novel protocol are total avoidance of the hyperstimulation syndrome and reduction in the risk of multiple pregnancies. Objective To evaluate the effect of 5-days extended culture of immature oocytes in pre-maturation medium (PMC) containing single maturation inhibitor on their meiotic resumption and embryonic development Design Experimental Study. Material and Methods Oocytes were cultured in prematuration culture media (PMC) for 120 h followed by 48 h in in maturation media. The PMC was M199 medium containing 10 μM of either maturation inhibitor of Roscovitine, Cilostamide, and Forskolin supplemented with 10% serum protein substitute (SPS).The maturation media was M199 media supplemented with 10% SPS and 7.5 IU FSH/LH . Two control groups were used. In control 1, immature oocytes were cultured in the same medium as the experimental group without any inhibitors. In the control 2 group, oocytes were cultured directly in the maturation medium supplemented with FSH/LH. In vitro matured oocytes were then inseminated with frozenthawed bull sperm. Fertilization, defines as2-cell division 48 h post-insemination, and blastocyst formation were recorded. Chi -square test was used for statistical analysis. Results A total of 555 oocytes were included in this study.
The maturation rate of Roscovitine and Cilostamide groups was significantly higher than the controls (P <0.05). Roscvitine had significantly higher fertilization rate when compared to other treatment groups (p=0.01 for Cilostamide, and 0.009 for forskolin). Blastocyt formation was higher in Roscovitine than other controls and treatment groups, however this rate was not significant (P>0.05).
Conclusion Based on this limited data, it seems that PMC of bovine oocytes in the presence of Roscovitine for a period of 5 days has an overall better outcome than Cilostamide or Forskolin. Support None.
Optimizing the in vitro maruration outcome of bovine oocytes by exposing to a combination of meiotic inhibitors in a prematuration culture period Objective To investigate the effect of using a combination of 2 of the inhibitors phosphodiesterase inhibtor-3; Cilostamide (Cil.), Adenylate cyclase activator ;Forskolin(Fo) and maturation promoting factor inhibitor ;Roscovitine (Ros) on the in vitro maturation outcome of bovine oocytes Design Experimental design. Material and Methods Oocytes were cultured in prematuration culture media (PMC) consisting of M199 medium containing 10 μM of a combination of 2 of the maturation inhibitors for 3 days and then transferred to maturation media containing 7.5 IU of FSH/LH for 48 h incubation. In the control group 1 the (PMC) was the basic maturation media with no maturation inhibitors for the same duration . In the control group 2, oocytes were only cultured in the maturation medium supplemented with 7.5 IU of FSH/LH directly for 48 h. Mature oocytes were then inseminated with frozen-thawed bull sperm. Fertilization, defined as 2-cell division 48 h post-insemination, and blastocyst formation were monitored. Chi-square test was used for statistical analysis Results A total of 553 oocytes were included with their IVM outcomes examined in all groups:
Our results were showing that the maturation rate of all the treated groups were significantly higher than the control l(p<0.05). The fertilization rate of (Cil+Ros) was significantly higher than the (Fo+Ros) and the control 1(p= 0.005 and 0.03, respectively). The blastulation rate of the (Cil+Ros) was the only significant among the treated groups Vs control1 (p=0.04).
Conclusion Temporary meiotic arrest of immature bovine oocytes using a combination of Cilostamide and Roscovitine for 3 days is associated with better embryonic developmental outcome. If applicable to human, this will improve the clinical IVM outcome. Support None. Should we isolate human primordial follicles before or after cryopreservation?
Efficacy of in vitro maturation of immature human oocytes
Vanacker J., Luyckx V., Amorim C.A., Dolmans M-M., Van Langendonckt A., Donnez J., Camboni A.
Introduction Although preantral follicles can be successfully isolated from frozen-thawed ovarian tissue, cryopreservation of isolated follicles could circumvent technical problems associated with cryopreservation of heterogeneous cell types. It would also allow quantitative and qualitative evaluation of the follicular population present in ovarian fragments. The aim of this study was to compare the viability and growth capacity of human preantral follicles isolated before and after cryopreservation. Material and Methods Six ovarian biopsies were cut into two equal parts. One half was subjected to slowfreezing (Van Eyck et al., 2009) and follicle isolation by Liberase DH digestion (Cryo-iso group) and the other was immediately processed for follicle isolation. Some of these fresh isolated follicles were slow-frozen (Iso-cryo group), while the remaining ones were used as fresh controls (Fresh group). Isolated follicles from all three groups were embedded in alginate and in vitro cultured for 7 days. After follicle isolation, cryopreservation and in vitro culture (IVC), follicular viability and diameter were analyzed. Some isolated follicles were fixed for transmission electron microscopy (TEM) analysis. Results A total of 1134 and 1132 preantral follicles were isolated from fresh and frozen biopsies respectively. Introduction Reintroduction of malignant cells by ovarian tissue autotransplantation in cancer patients seeking fertility preservation is still a risk. Therefore, ovarian tissue cryopreservation and in vitro culture followed by isolation and in vitro maturation of follicles and oocytes could be a safer strategy.
Objective To evaluate primordial follicle growth and hormone production after in vitro culture of fresh and cryopreserved/thawed murine ovaries using a new dynamic culture system.
Materials & Methods Ovaries were obtained from 96 adult female C57BL/6 mice. Half of these ovaries were cryopreserved/thawed via slow freezing/rapid thawing. Ovaries were then distributed into 4 culture groups: Fresh Static (FS), Fresh Dynamic (FD), Cryopreserved Static (CS) and Cryopreserved Dynamic (CD). Static cultures acted as control groups while dynamic cultures acted as study groups and were continuously perifused via a peristaltic pump. For all groups, ovaries were cultured in G-MOPS medium for 6 days. Before and after culture, ovaries were randomly sectioned and examined histologically for viability and follicle classification. During culture, Estradiol (E2) and Progesterone (P) were measured daily.
Results Confirmed by decreased primordial follicles (PF)% and increased growing follicles (GF)%, growth of primordial follicles into growing follicles was significantly higher in FD compared with FS (PF/GF% ratio 9/91 vs 17.6/82.4; p<0.001), and in CD compared with CS (PF/GF% ratio 5.8/94.2 vs 8.7/91.3; p=0.026). Combined E2 and P production was comparable in FD to FS (81% vs 80%), and significantly higher in CD compared with CS (60% vs 6%; p=0.005). Viability % (Mean±SEM) was comparable in FD to FS (86.1±3.8 vs 84±3.8), and in CD to CS (70.1±5.4 vs 64±5.1). Conclusion Compared to static cultures, dynamic cultures showed significantly higher primordial follicle growth and hormone production especially in cryopreserved/thawed murine ovaries. Support University funding.
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Direct effect of ovarian tissue cryopreservation on in vitro maturation, fertilization and embryonic development of murine oocytes
Winkler Katharina, Salama Mahmoud, Murach Karl-Friedrich, Hofer Susanne, Wildt Ludwig, Ziehr Stephanie C.
Introduction Ovarian tissue cryopreservation is a promising fertility preservation strategy. It has been described that predominately primordial and small preantral follicles do survive ovarian tissue cryopreservation and thawing, whereas less attention has been paid to its direct impact on the oocyte. Therefore the aim of this study was to assess the effect of ovarian tissue cryopreservation and thawing on the oocytes capability to undergo in vitro maturation fertilization and embryo development in the mouse model. Materials and Methods Ovaries (n=13) were collected from 7-week-old BALB/c mice and cryopreserved following a slow freezing protocol using DMSO, ethylene glycol and sucrose as cryoprotectants without previous stimulation-/superovulation-treatment. 
, Renato Fanchin
Objective To compare the results of IVM of oocytes for FP in women having undergone oocytes retrieval during the follicular or the luteal phase. Materials and Methods 63 candidates for urgent FP using IVM of oocytes were prospectively studied. In all patients, serum AMH levels and antral follicle count (AFC ; 3-12 mm in diameter) were measured prior to immature oocyte retrieval, irrespective of the cycle day. Patients were set into 2 groups according to the phase of the cycle in which egg retrieval was performed (Follicular Group, n=34 and Luteal Group, n=29). In both groups, oocyte retrieval was performed under ultrasound guidance after hCG administration. Number of immature oocytes recovered, maturation rate after 24 h and 48 h of culture, fertilization rates and total number of oocytes or embryos cryopreserved were assessed. In addition, the oocyte output rate was calculated by AFCx100/number of immature oocytes recovered. Comparisons between continuous and categorical variables in the Follicular and Luteal groups were assessed using Mann Whitney test and the twosided Pearson X 2 test, respectively. Results Overall, women of the Follicular and the Luteal groups were comparable in terms of age (30 (18-38) vs. 29 (20-39) years, respectively), serum AMH levels (3.2 (1.1-7.8) vs. 3.2 (0.48-11.5) ng/mL, respectively) and AFC (17 (5-44) vs. 17 (4-38) follicles, respectively). In addition, there were no significant differences in the number of oocyte recovered, and in the oocyte output rate (6 (0-21) vs. 6 (0-28) follicles and 43.7%±4.5 vs. 41.0%±5.1, respectively). Moreover, maturation rates after 24 h and 48 h of culture, fertilization rates as well as the total number of oocytes and embryos cryopreserved were similar in both groups. Objective Lysophosphatidic acid (LPA) is a small phospholipid that acts as an extracellular signaling molecule by binding to and activating at least five known G proteincoupled receptors (GPCRs) such as LPA1 to 5. The biological actions of LPA are various and include developmental, physiological, and pathophysiological effects. Studies in many species including mice and humans have suggested important roles for receptor-mediated LPA signaling in multiple aspects of reproduction. Here we investigated the effect of LPA supplementation on mouse oocyte maturation Materials and Methods Immature oocytes from 5 to 6 weekold female BDF-1 mice were incubated in maturation medium containing LPA with three different doses (1, 10, and 30 μM) for 17-18 h. After in-vitro maturation, fertilization and blastocyst formation were assessed. Results Immature oocytes treated with 10 μM and 30 μM of LPA showed significantly higher maturation rate than control group (91.6, 94.3, and 80.5% for LPA 10 μM, LPA 30 μM, and control group, respectively). In addition, 30 μM of LPA supplementation significantly improved fertilization, blastocyst formation, and hatching rate when compared with control group (96.3, 79.1, and 51.3%, for LPA 30 μM supplementation group and 87.5, 61.3, and 37.8% for control group respectively). Conclusions Considering developmental competency, supplementation of LPA to oocyte maturation medium could be beneficial for development of immature mouse oocytes. Support None
